Estrogens control inflammation in experimental colitis

Area of Science:

• Gastroenterology
• Endocrinology
• Immunology

Background:

• Estrogen deficiency is linked to increased inflammation.
• Estrogen replacement therapy may counteract inflammatory processes.
• The role of estrogen in controlling intestinal inflammation requires further investigation.

Purpose of the Study:

• To investigate the protective role of estrogen in experimental colitis models.
• To evaluate the effects of estrogen on morphological and molecular markers of intestinal inflammation.
• To assess estrogen's impact on mast cell activity, cytokine expression, fibronectin, and reactive oxygen species.

Main Methods:

• Adult male rats were divided into four groups: control, colitis-induced, colitis-induced with estrogen treatment, and estrogen-only treatment.
• Colitis was induced using four different models: iodoacetamide, iodoacetamide + enteropathogenic E. coli, 2,4,6-Trinitrobenzene sulfonic acid, and dextran sulfate sodium salt.
• Macroscopic, microscopic, and molecular analyses were performed at multiple time points (days 7, 14, 28, and 56).

Main Results:

• Estrogen-treated rats showed significant health improvements, with reduced inflammation scores (10-15%).
• A decrease in mast cell count (30%), fibronectin expression (50%), and reactive oxygen species (30%) was observed in estrogen-treated groups.
• Estrogen treatment led to a significant reduction in pro-inflammatory cytokine expression, including TNF-alpha, IL-6, and IL-1beta (approximately 25%).

Conclusions:

• Estrogen administration improved the inflammatory status in all experimental colitis models.
• Estrogen exhibited a marked antioxidant effect and reduced tissue necrosis, indicated by lower fibronectin levels.
• These findings support estrogen's therapeutic potential in managing intestinal inflammation.